I am a recent graduate of Florida State University with a degree in STEM Entrepreneurship, focused on advancing solutions for rare diseases—particularly trimethylaminuria (TMAU). During my time on the FSU iGEM team, I began working on what became Esperance Healthcare. I am now a co-founder, developing engineered probiotics designed to support metabolic function and address unmet patient needs. My work centers on translating synthetic biology into accessible, patient-centered solutions, with the goal of building scalable biotech ventures that bring meaningful progress to underserved rare disease communities.